Salem, Ore.-based Agility Robotics, whose two-legged Digit robots have been tested inside Amazon warehouses, is set to become the first publicly traded U.S. company dedicated solely to humanoid robots ...

The AI infrastructure boom has driven an outsized number of stocks to gains of 100% or more in the past year, Morningstar data shows. A few of these stocks, including SanDisk, have risen over 1,000% ...

The Spurs face an uphill battle in the 2026 NBA Finals. San Antonio has held double-digit leads in both games of the Finals against the Knicks—a 14-point lead in Game 1 and a 12-point lead in Game ...

In an era dominated by social media, misinformation has become an all too familiar foe, infiltrating our feeds and sowing seeds of doubt and confusion. With more than half of social media users across ...

Wall Street is mistaken to insist that the bull market can’t be in danger because corporate earnings are growing fast. Blistering earnings growth of the kind that S&P 500 SPX companies have been ...

Personalized algorithms may quietly sabotage how people learn, nudging them into narrow tunnels of information even when they start with zero prior knowledge. In the study, participants using ...

Apple released iOS 26.4.2 as the second mid-release update for iOS 26.4, addressing unspecified bugs and security vulnerabilities. The update fixes a critical Notification Services vulnerability ...

William Parks is a Game Rant editor who specializes in puzzle games, indie releases, Nintendo titles, and completion-focused guide coverage. Since joining Game Rant in 2019, he has written and edited ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...

Every weekend, Scott White ranks the two-start pitchers for the upcoming scoring period and then categorizes them by how usable they are. The names depicted here require some forecasting and are, ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) – the first and only cleared for ...